@PlanTrader
You're probably right...I've said many times that I am unqualified to talk to trial process & science...I just know from reading what the normal sequence is: data lock, top line data, and full data...if successful FDA gets info and then shareholders.
Geert has said many times that he will not report top line and will wait for proof by reporting full data.
The short sellers think he is withholding information as long as possible because they think he has poor data, Geert has 4 mil shares and options...and is openly challenging them, but each time he speaks the stock is hit generating profits for option sellers with those premiums fading like ice in a sauna.
Some think July and we know there is an outstanding S-1 to sell and exercise many insider option grants & warrants....some coming due mid-June, but Geert has a history of EXTENDING them without notice.
I watch, as best as possible, price, volume, patterns, support, resistance, potential turning spots (50 day & 200 day) where I think I can offer some opinion...without any guarantee, naturally!
News 
Market Data 
Discover 
